Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology.
Reverse Type 2 Diabetes Without Medication with Dr. Kathleen Nash
Dr. Kathleen Nash shares how to potentially reverse Type 2 diabetes naturally, without medication, through metabolic changes based on her personal 80-pound weight loss journey. #PaidForContent
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study. A class of drugs for diabetes may be associated with a lower risk ...
Study links diabetes drugs to lower risk of dementia and Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the .
Some Diabetes Meds Could Lower Odds for Dementia, Parkinson's
A specific class of diabetes drug appears to lower people’s risk for dementia and Parkinson’s disease, a new study shows. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, also known as gliflozins, lower blood sugar by prompting the kidneys to filter sugar out of the bloodstream and excrete it in urine,
ScienceAlert on MSN2d
Common Diabetes Medication Slows Brain Aging in Monkeys
Metformin is the main first-line drug used to treat type 2 diabetes, but a new study on monkeys suggests it could one day be ...
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
News Medical13d
Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing
Research shows elevated metformin in diabetic foot ulcer exudates when combined with insulin, highlighting potential for ...
Study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...
FTC sues pharmacy insurance managers, alleging unfair drug prices
The FTC accuses the largest pharmacy benefit manager companies of unfairly boosting prices on prescription drugs.